Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism

Table 1

Clinical and demographical characteristics of the patient population.

	Subclinical hypothyroidism	Clinical hypothyroidism	Subclinical hyperthyroidism	Clinical hyperthyroidism	Control
Gender (F/M)	13/3	14/2	13/3	11/5	9/11
Age (years)	40,8±11,8	38,0±10,2	41,6±16,4	41,6±11,8	32,8±5,7
BMI (kg/m^2)	26,72±2,32^∗	27,14±2,25^∗	24,65±3,07	24,48±1,84	24,34±2,43
MAP (mmHg)	88,8±12,0	86,4±9,6	84,9±9,7	88,2±10,6	80,0±11,7
TSH (ìIU/mL)	6,91±1,74^∗	29,87±23,65^∗	0,12±0,09^∗	0,01±0,02^∗	1,39±0,68^∗
sT3 (pg/mL)	3,02±0,67	2,52±0,92	3,46±0,53	6,7±3,33	3,22±0,97
sT4 (ng/dL)	1,13±0,24	0,76±0,29	1,33±0,18	2,90±1,70	1,4±0,19
T.cholestrol (mg/dL)	204±41^∗	207±69^∗	181±28	147±40	164±27
Triglyceride (mg/dL)	186±127	141±28	158±76	105±57	104±44
HDL (mg/dL)	41±8	43±7	41±6	41±10	42±11
LDL (mg/dL)	126±34^∗	135±63^∗	110±28	85±31	111±41
CA-IMT (mm)	0,61±0,11	0,62±0,13	0,58±0,17	0,59±0,15	0,53±0,08

^∗𝑃<0.05.
F: female; M: male; BMI: body mass index; MAP: mean arterial pressure; TSH: thyroid stimulating hormone; HDL: high-density lipoprotein; LDL: low-density lipoprotein; CA-IMT: carotid intima media thickness.